These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18586912)

  • 1. Low-affinity major histocompatibility complex-binding peptides in type 1 diabetes.
    James EA; Kwok WW
    Diabetes; 2008 Jul; 57(7):1788-9. PubMed ID: 18586912
    [No Abstract]   [Full Text] [Related]  

  • 2. Weak proinsulin peptide-major histocompatibility complexes are targeted in autoimmune diabetes in mice.
    Levisetti MG; Lewis DM; Suri A; Unanue ER
    Diabetes; 2008 Jul; 57(7):1852-60. PubMed ID: 18398138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A TCR-like antibody against a proinsulin-containing fusion peptide ameliorates type 1 diabetes in NOD mice.
    Matsumoto Y; Kishida K; Matsumoto M; Matsuoka S; Kohyama M; Suenaga T; Arase H
    Biochem Biophys Res Commun; 2021 Jan; 534():680-686. PubMed ID: 33208230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new look at MHC and autoimmune disease.
    Ridgway WM; Fassò M; Fathman CG
    Science; 1999 Apr; 284(5415):749, 751. PubMed ID: 10336398
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence that a peptide spanning the B-C junction of proinsulin is an early Autoantigen epitope in the pathogenesis of type 1 diabetes.
    Chen W; Bergerot I; Elliott JF; Harrison LC; Abiru N; Eisenbarth GS; Delovitch TL
    J Immunol; 2001 Nov; 167(9):4926-35. PubMed ID: 11673498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promiscuous binding of proinsulin peptides to Type 1 diabetes-permissive and -protective HLA class II molecules.
    Astill TP; Ellis RJ; Arif S; Tree TI; Peakman M
    Diabetologia; 2003 Apr; 46(4):496-503. PubMed ID: 12684749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell receptor-transgenic NOD mice: a reductionist approach to understand autoimmune diabetes.
    Yang Y; Santamaria P
    J Autoimmun; 2004 Mar; 22(2):121-9. PubMed ID: 14987740
    [No Abstract]   [Full Text] [Related]  

  • 8. Understanding the interaction of genetics and cellular responses in nonobese diabetic mice.
    Ridgway WM; Fathman CG
    Curr Dir Autoimmun; 2001; 4():218-38. PubMed ID: 11569404
    [No Abstract]   [Full Text] [Related]  

  • 9. IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule.
    Trembleau S; Gregori S; Penna G; Gorny I; Adorini L
    J Immunol; 2001 Oct; 167(7):4104-14. PubMed ID: 11564833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Faulty major histocompatibility complex class I function linked to autoimmune diabetes.
    Faustman D
    Transplant Proc; 1992 Dec; 24(6):2874-6. PubMed ID: 1465979
    [No Abstract]   [Full Text] [Related]  

  • 11. Failure of a protective major histocompatibility complex class II molecule to delete autoreactive T cells in autoimmune diabetes.
    Slattery RM; Miller JF; Heath WR; Charlton B
    Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10808-10. PubMed ID: 7902572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-peptides that bind with low affinity to the diabetes-associated I-A(g7) molecule readily induce T cell tolerance in non-obese diabetic mice.
    Ferlin WG; Mougneau E; Hugues S; Appel H; Jang MH; Cazareth J; Beaudoin L; Schricke C; Lehuen A; Wucherpfennig KW; Glaichenhaus N
    Eur J Immunol; 2004 Oct; 34(10):2656-63. PubMed ID: 15368281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and pathogenic basis of autoimmune diabetes in NOD mice.
    Serreze DV; Leiter EH
    Curr Opin Immunol; 1994 Dec; 6(6):900-6. PubMed ID: 7710714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APC-targeted proinsulin expression inactivates insulin-specific memory CD8
    Reeves PL; Rudraraju R; Liu X; Wong FS; Hamilton-Williams EE; Steptoe RJ
    Immunol Cell Biol; 2017 Oct; 95(9):765-774. PubMed ID: 28611473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.
    Gregori S; Trembleau S; Penna G; Gallazzi F; Hammer J; Papadopoulos GK; Adorini L
    J Immunol; 1999 Jun; 162(11):6630-40. PubMed ID: 10352280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Processing and presentation of (pro)-insulin in the MHC class II pathway: the generation of antigen-based immunomodulators in the context of type 1 diabetes mellitus.
    Burster T; Boehm BO
    Diabetes Metab Res Rev; 2010 May; 26(4):227-38. PubMed ID: 20503254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of effectors and regulators are decisive in the manifestations of type 1 diabetes in nonobese diabetic mice.
    Quinn A; Kumar V; Jensen KP; Sercarz EE
    Curr Dir Autoimmun; 2001; 4():171-92. PubMed ID: 11569402
    [No Abstract]   [Full Text] [Related]  

  • 18. The association of MHC with autoimmune diseases: understanding the pathogenesis of autoimmune diabetes.
    Ridgway WM; Fathman CG
    Clin Immunol Immunopathol; 1998 Jan; 86(1):3-10. PubMed ID: 9434791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfer of hematopoietic stem cells encoding autoantigen prevents autoimmune diabetes.
    Steptoe RJ; Ritchie JM; Harrison LC
    J Clin Invest; 2003 May; 111(9):1357-63. PubMed ID: 12727927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoptive transfer of islet antigen-autoreactive T cell clones to transgenic NOD.Ea(d)mice induces diabetes indicating a lack of I-E mediated protection against activated effector T cells.
    Roberts SA; Barbour G; Matarrese MR; Mason DL; Leiter EH; Haskins K; Hanson MS
    J Autoimmun; 2003 Sep; 21(2):139-47. PubMed ID: 12935783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.